Research on the legal issues of drug price supervision
After three years of epidemics,people have become the first responsible for their health,and the guarantee of accessibility and affordability of medicines is a rigid demand to improve people's health.The drug price reform measures to reduce drug prices and ensure the accessibility and affordability of drugs for the public have been carried out frequently,but the effectiveness of the reform has always been different from the expected goal of the drug price reform,and the Drug Administration Law has not solved the problem of drug price regulation from the root.The fundamental reason is that the existing legal system involves the neglect of the drug price regulation dilemma rooted in information asymmetry.This paper analyzed the special characteristics of drugs with the quasi-public product the-ory,provided legitimacy and legality for the regulation of drug prices different from ordinary commodities,analyzed the sta-tus quo of information asymmetry in the drug market with the"principal-agent",solved the difficulties and pain points in the regulation of drug prices at the root,and promoted the"last step"of Healthy China.
Principal-agentAsymmetry informationQuasi public goodsDrug price regulation
NETL
NSTL
万方数据
